Matthew Hershenhorn

Stock Analyst at Oppenheimer

(1.92)
# 3,908
Out of 4,853 analysts
1
Total ratings
100%
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matthew Hershenhorn

Axsome Therapeutics
Jun 3, 2025
Initiates: Outperform
Price Target: $185
Current: $110.66
Upside: +67.18%